Feed KALA
KA
Kala Pharmaceuticals, Inc.
KALA · NASDAQ
$0.75 -0.35% (-$0.00)
1M -44.61%
Market Cap $14.2M
P/E Ratio -
Div. Yield -
ROE 1,335.64%
Bulios Fair Price
$0.85
13.7% upside
Preț actual
$0.75
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile KALA sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 1.32x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 28.29%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 1,335.64%
ROA 159.56%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 7.91x
Int. coverage -1.43x
Debt/Equity 0.00x
Stability
62 /100
Moderate EPS volatility 9.39%
Profitable years 0
Beta -2.36x
Întreabă StockBot despre KALA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Avi Minkowitz
Employees
6
Headquarters
Arlington
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report